Xtant Medical to Issue Third Quarter 2020 Financial Results on October 29, 2020
Xtant Medical Holdings (XTNT) is set to release its third quarter financial results for the period ending September 30, 2020, on October 29, 2020, before market open. A conference call featuring CEO Sean Browne and CFO Greg Jensen will take place on the same day at 9 AM ET to discuss the results. The call can be accessed via dial-in or webcast. Xtant Medical specializes in surgical solutions for spinal disorders, with a focus on orthobiologics and spinal implant systems.
- Scheduled release of third quarter financial results on October 29, 2020.
- Leadership engagement through a conference call to discuss financial outcomes.
- None.
BELGRADE, Mont., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2020, before the open of the financial markets on Thursday, October 29, 2020.
Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Thursday, October 29 at 9:00 AM ET to review results.
Conference Call Details
Date: Thursday, October 29, 2020 – 9:00 AM ET
Dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Third Quarter 2020 Financial Results
Webcast Registration: Click Here
Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
Investor Relations Contact
David Carey
Lazar FINN Partners
Ph: 212-867-1768
Email: david.carey@finnpartners.com
FAQ
When will Xtant Medical release its Q3 2020 financial results?
What time is the Xtant Medical Q3 2020 conference call?
Who will speak on the Xtant Medical conference call?